Clinical Research Disease Drug Trials Pharmacokinetics 
Drug Discovery World
FEBRUARY 20, 2023
Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. Here, we take a look at the top four disease areas and some of the key developments in 2022. The post What are the top disease areas for clinical drug trials?
Alta Sciences
JULY 31, 2024
Regulatory organizations like Health Canada, the International Council for Harmonisation (ICH), and the European Medicines Agency (EMA) have long emphasized the importance of including diverse populations in clinical research. For example, elderly individuals are more prone to comorbidities, dementia, and functional decline.
Expert insights. Personalized for you.
130 
Let's personalize your content